Newsletter January 2019
Our biggest milestone last year was the first closing of our fifth fund in July 2018 with more than 90 million euros. We are also very pleased to have made our first investment from SHS V at the end of the year. We invested in evitria AG, a Swiss supplier for the life science industry.
In the last months of the year, our portfolio companies developed very successfully: EIT was sold to Johnson & Johnson, while SIS Medical, TRI Dental Implants and Tyromotion each expanded their product portfolios. TNI medical and SIS succeeded in entering a market outside Europe.
We at SHS are starting the new year with an extended team. Patrick Frohnheiser is strengthening the investment team and Heike Kittel the controlling team. Dr. Markus Enzelberger has also joined our Venture Advisors team.
I hope you enjoy reading!